sertraline has been researched along with Cardiac Arrest, Sudden in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC | 2 |
Assimon, MM; Brookhart, MA; Flythe, JE | 1 |
Gillespie, JA | 1 |
4 other study(ies) available for sertraline and Cardiac Arrest, Sudden
Article | Year |
---|---|
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Death, Sudden, Cardiac; Escitalopram; Humans; Proton Pump Inhibitors; Renal Dialysis; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2022 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 2019 |
Comment: sudden cardiac death with clozapine and sertraline combination.
Topics: Antipsychotic Agents; Clozapine; Death, Sudden, Cardiac; Drug Combinations; Humans; Male; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |